Anto Biosciences is an AI driven biotech developing gut microbiome computable to predict and optimize drug efficacy.
Anto Biosciences has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in December 2025.
Anto Biosciences's investors include Y Combinator.
Anto Biosciences is headquartered in San Francisco, United States.
Anto Biosciences is an AI driven biotech developing gut microbiome computable to predict and optimize drug efficacy.
Anto Biosciences is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Anto Biosciences — Funding & Investors." VCBacked, December 3, 2025, https://www.vcbacked.co/company/anto-biosciences. Accessed July 19, 2026.
VCBacked. (2025). Anto Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/anto-biosciences
{{cite web |title=Anto Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/anto-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated